🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
Historically cutaneous and peripheral T-cell lymphomas have response rates ...
Status
Completed
Location
University of Michigan Hospital
Start Date
2014-09
Trial ID
NCT02158975
Treatments Being Tested
This is a phase II, multicenter, open-label study to evaluate the safety an...
Status
Completed
Location
CHRU - Hôpital du Haut Lévêque
Start Date
2014-11-12
Trial ID
NCT01936532
Treatments Being Tested
A Phase 1/2a study to assess the safety, tolerability, PK and biological ac...
Status
Recruiting
Location
Emory Winship Cancer Institute
Start Date
2019-08-09
Trial ID
NCT04068597
This is a single center, open-label, phase 2 study in elderly (age ≥ 70) su...
Status
Active Not Recruiting
Location
Icahn School of Medicine at Mount Sinai
Start Date
2019-10-24
Trial ID
NCT04052880
Treatments Being Tested
The purpose of this research study is to find out how well ixazomib (the st...
Status
Completed
Location
University of Wisconsin Hospital and Clinics
Start Date
2017-09-15
Trial ID
NCT03213158
Treatments Being Tested
This study mainly evaluated the efficacy and safety of autologous stem cell...
Status
Enrolling By Invitation
Location
National Clinical Research Center of Kidney Diseases, Jinling Hospital
Start Date
2010-07-01
Trial ID
NCT04210791
This phase I trial studies the side effects and best dose of venetoclax whe...
Status
Completed
Location
University of Michigan Rogel Cancer Center
Start Date
2018-05-02
Trial ID
NCT03399539
Treatments Being Tested
This phase I trial studies the side effects and best dose of daratumumab, i...
Status
Completed
Location
M D Anderson Cancer Center
Start Date
2018-02-07
Trial ID
NCT03283917
Treatments Being Tested
A Phase IB/II Trial of Lenalidomide (Revlimid®), Ixazomib and Rituximab (RI...
Status
Terminated
Location
University Hospitals, Seidman Cancer Center, Case Comprehensive Cancer Center
Start Date
2017-02-20
Trial ID
NCT02898259
Treatments Being Tested
The study seeks to investigate safety and efficacy of ixazomib (NINLARO), a...
Status
Recruiting
Location
Royal London Hospital, Barts Health NHS Foundation Trust
Start Date
2020-06-15
Trial ID
NCT03783416
Treatments Being Tested